MHRA Public Consultation on Reclassification of Aquiette 2.5mg Tablets (Oxybutynin Hydrochloride) to a Pharmacy Medicine MHRA Public Consultation on Reclassification of Aquiette 2.5mg Tablets (Oxybutynin Hydrochloride) to a Pharmacy Medicine MHRA has launched a... MHRA Public Consultation on Reclassification of Aquiette 2.5mg Tablets (Oxybutynin Hydrochloride) to a Pharmacy Medicine
EU Exit – Supply of Medicines to Northern Ireland & Cyprus, Ireland and Malta – Directive Published EU Exit – Supply of Medicines to Northern Ireland & Cyprus, Ireland and Malta – Directive Published Further to the... EU Exit – Supply of Medicines to Northern Ireland & Cyprus, Ireland and Malta – Directive Published
PAGB Briefing Paper on Titanium Dioxide PAGB Briefing Paper on Titanium Dioxide PAGB has released a briefing paper in response to the ban of titanium dioxide... PAGB Briefing Paper on Titanium Dioxide
PAGB OTC Medicines Packaging Workshop PAGB OTC Medicines Packaging Workshop PAGB will be running the workshop “OTC Medicines Packaging: successful submissions and how to make... PAGB OTC Medicines Packaging Workshop
EMA HMPC Launches Calls for Submission of Scientific Data EMA HMPC Calls for Submission of Scientific Data The European Medicines Agency’s (EMA) Committee on Herbal Medicinal Products (HMPC) has... EMA HMPC Launches Calls for Submission of Scientific Data
MHRA Consultation on a New Code of Practice for the Expert Advisory Committees MHRA Consultation on a New Code of Practice for the Expert Advisory Committees MHRA is inviting a range of stakeholders... MHRA Consultation on a New Code of Practice for the Expert Advisory Committees
EMA Launch of GCP Inspections Management in IRIS Platform EMA Launch of GCP Inspections Management in IRIS Platform The European Medicines Agency (EMA) has announced that the management of... EMA Launch of GCP Inspections Management in IRIS Platform
EMA – Public Consultation on Updated Product-Specific Bioequivalence Guidance EMA – Public Consultation on Product-Specific Bioequivalence Guidance The European Medicines Agency (EMA) has published the following draft product-specific bioequivalence... EMA – Public Consultation on Updated Product-Specific Bioequivalence Guidance
MHRA – Updated Approved Reclassifications in ‘Medicines: Reclassify Your Product’ Guidance MHRA – Updated Approved Reclassifications in ‘Medicines: Reclassify Your Product’ Guidance The MHRA has updated the approved reclassifications up to... MHRA – Updated Approved Reclassifications in ‘Medicines: Reclassify Your Product’ Guidance
CMDh March 2022 Meeting – Report CMDh March 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh March 2022 Meeting – Report
Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs Update on Nitrosamines The European Medicines Agency (EMA) and the Co-ordination group for Mutual recognition and Decentralised procedures – human... Update on Nitrosamines – EMA/CMDh Publishes Revised Version of Q&A Document for MAHs
MHRA Board Meeting – 19 April 2022 MHRA (Medicines and Healthcare products Regulatory Agency) Board Meeting – 19 April 2022 The MHRA Board will meet in public... MHRA Board Meeting – 19 April 2022
